Continue to site >
Trending ETFs

BlackRock Future Health ETF

Active ETF
BMED
Payout Change
None
Price as of:
$22.6 +0.42 +1.89%
primary theme
Health Care Sector Equity
BMED (ETF)

BlackRock Future Health ETF

Payout Change
None
Price as of:
$22.6 +0.42 +1.89%
primary theme
Health Care Sector Equity
BMED (ETF)

BlackRock Future Health ETF

Payout Change
None
Price as of:
$22.6 +0.42 +1.89%
primary theme
Health Care Sector Equity

Name

Price

Aum/Mkt Cap

YIELD

Exp Ratio

Watchlist

BlackRock Future Health ETF

BMED | Active ETF

$22.60

$7.24 M

0.00%

0.85%

Vitals

YTD Return

-16.0%

1 yr return

-22.1%

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$7.24 M

Holdings in Top 10

26.0%

52 WEEK LOW AND HIGH

$22.2
$20.76
$31.13

Expenses

OPERATING FEES

Expense Ratio 0.85%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A


Min Investment

Standard (Taxable)

N/A

IRA

N/A


Fund Classification

Fund Type

Exchange Traded Fund


Name

Price

Aum/Mkt Cap

YIELD

Exp Ratio

Watchlist

BlackRock Future Health ETF

BMED | Active ETF

$22.60

$7.24 M

0.00%

0.85%

BMED - Profile

Distributions

  • YTD Total Return -21.8%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency N/A
  • Net Income Ratio -0.64%
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annually

Fund Details

  • Legal Name
    BlackRock Future Health ETF
  • Fund Family Name
    BlackRock
  • Inception Date
    Sep 29, 2020
  • Shares Outstanding
    320000
  • Share Class
    N/A
  • Currency
    USD
  • Domiciled Country
    United States
  • Manager
    Xiang Liu

Fund Description


BMED - Performance

Return Ranking - Trailing

Period BMED Return Category Return Low Category Return High Rank in Category (%)
YTD -16.0% -25.6% 23.4% 97.24%
1 Yr -22.1% -27.6% 26.0% 98.20%
3 Yr N/A* -18.9% 19.7% N/A
5 Yr N/A* -15.2% 15.3% N/A
10 Yr N/A* -5.7% 16.3% N/A

* Annualized

Return Ranking - Calendar

Period BMED Return Category Return Low Category Return High Rank in Category (%)
2022 -4.0% -53.9% 11.7% 10.78%
2021 N/A -22.3% 18.5% N/A
2020 N/A -4.7% 41.4% N/A
2019 N/A -10.2% 13.1% N/A
2018 N/A -5.7% 26.9% N/A

Total Return Ranking - Trailing

Period BMED Return Category Return Low Category Return High Rank in Category (%)
YTD -21.8% -41.2% 23.4% 97.24%
1 Yr -22.1% -28.5% 28.3% 98.32%
3 Yr N/A* -18.9% 19.7% N/A
5 Yr N/A* -15.2% 15.3% N/A
10 Yr N/A* -5.7% 16.3% N/A

* Annualized

Total Return Ranking - Calendar

Period BMED Return Category Return Low Category Return High Rank in Category (%)
2022 -4.0% -53.9% 11.7% 10.78%
2021 N/A -22.3% 18.5% N/A
2020 N/A -4.7% 41.4% N/A
2019 N/A -10.2% 13.1% N/A
2018 N/A -5.7% 26.9% N/A

BMED - Holdings

Concentration Analysis

BMED Category Low Category High BMED % Rank
Net Assets 7.24 M 732 K 46.2 B 87.37%
Number of Holdings 134 3 507 17.50%
Net Assets in Top 10 1.88 M 2.18 K 21.6 B 93.50%
Weighting of Top 10 25.98% 12.3% 100.0% 94.00%

Top 10 Holdings

  1. BlackRock Cash Funds Treasury SL Agency 4.97%
  2. Seattle Genetics Inc 3.76%
  3. Genmab A/S 3.54%
  4. Genmab A/S 3.54%
  5. Genmab A/S 3.54%
  6. Genmab A/S 3.54%
  7. Genmab A/S 3.54%
  8. Genmab A/S 3.54%
  9. Genmab A/S 3.54%
  10. Genmab A/S 3.54%

Asset Allocation

Weighting Return Low Return High BMED % Rank
Stocks
94.94% 0.09% 106.13% 90.00%
Cash
5.06% -0.10% 99.91% 8.50%
Preferred Stocks
0.00% 0.00% 7.86% 49.50%
Other
0.00% -22.99% 3.38% 54.50%
Convertible Bonds
0.00% 0.00% 0.37% 49.50%
Bonds
0.00% 0.00% 12.39% 48.00%

Stock Sector Breakdown

Weighting Return Low Return High BMED % Rank
Healthcare
97.16% 26.56% 100.00% 84.00%
Financial Services
1.85% 0.00% 8.43% 1.00%
Basic Materials
0.99% 0.00% 14.83% 9.00%
Utilities
0.00% 0.00% 1.52% 46.50%
Technology
0.00% 0.00% 28.70% 51.50%
Real Estate
0.00% 0.00% 7.13% 50.50%
Industrials
0.00% 0.00% 7.02% 51.00%
Energy
0.00% 0.00% 0.00% 46.00%
Communication Services
0.00% 0.00% 12.28% 50.00%
Consumer Defense
0.00% 0.00% 25.73% 54.00%
Consumer Cyclical
0.00% 0.00% 14.20% 49.50%

Stock Geographic Breakdown

Weighting Return Low Return High BMED % Rank
US
80.25% 0.09% 104.41% 65.50%
Non US
14.69% 0.00% 45.40% 33.50%

BMED - Expenses

Operational Fees

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 0.85% 0.08% 3.13% 46.53%
Management Fee 0.85% 0.00% 1.25% 85.79%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.03% 0.25% N/A

Sales Fees

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 0.00% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

BMED Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 0.00% 238.00% N/A

BMED - Distributions

Dividend Yield Analysis

BMED Category Low Category High BMED % Rank
Dividend Yield 0.00% 0.00% 2.44% 55.12%

Dividend Distribution Analysis

BMED Category Low Category High Category Mod
Dividend Distribution Frequency Annually Annually Quarterly Annually

Net Income Ratio Analysis

BMED Category Low Category High BMED % Rank
Net Income Ratio -0.64% -2.54% 1.92% 80.00%

Capital Gain Distribution Analysis

BMED Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Annually

Distributions History

View More +

BMED - Fund Manager Analysis

Managers

Xiang Liu


Start Date

Tenure

Tenure Rank

Sep 29, 2020

1.67

1.7%

Director of BlackRock since 2016. Prior to joining BlackRock in 2008, Mr. Liu was a Partner and Biotech Analyst at Mehta Partners. Mr. Liu began his investment career in 2000 and has a BS from the University of Science & Technology (China), an MBA from the University of Chicago and a PhD degree in Chemistry from Yale University.

Erin Xie


Start Date

Tenure

Tenure Rank

Sep 29, 2020

1.67

1.7%

Ms. Xie is the managing director and Portfolio Manager of BlackRock Advisor since 2006. Before becoming part of BlackRock Advisors in 2005, she was with State Street Research & Management since 2001. Ms. Xie began her investment career as a pharmaceutical analyst for Sanford Bernstein in 1999.

Jeff Lee


Start Date

Tenure

Tenure Rank

Sep 29, 2020

1.67

1.7%

Director of BlackRock since 2011. Mr. Lee began his investment career in 2006 and has a BA from Princeton University

Tenure Analysis

Category Low Category High Category Average Category Mode
0.02 24.72 7.26 2.12